ATE194775T1 - Calcitonin enthaltende pharmazeutische zusammensetzungen - Google Patents

Calcitonin enthaltende pharmazeutische zusammensetzungen

Info

Publication number: ATE194775T1
Authority: AT; Austria
Prior art keywords: pharmaceutical compositions; compositions containing; containing calcitonin; calcitonin; calcium deficiency
Prior art date: 1991-04-23

Application number

AT92303554T

Other languages

English (en)

Inventor

Tudor Arvinte

Amelia Cudd

Judith Phillips

Original Assignee

Novartis Erfind Verwalt Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-04-23

Filing date

1992-04-21

Publication date

2000-08-15

1992-04-21 Application filed by Novartis Erfind Verwalt Gmbh filed Critical Novartis Erfind Verwalt Gmbh

2000-08-15 Application granted granted Critical

2000-08-15 Publication of ATE194775T1 publication Critical patent/ATE194775T1/de

Links

102000055006 Calcitonin Human genes 0.000 title abstract 2
108060001064 Calcitonin Proteins 0.000 title abstract 2
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 title abstract 2
229960004015 calcitonin Drugs 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 1
206010006956 Calcium deficiency Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Rheumatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Peptides Or Proteins (AREA)

AT92303554T 1991-04-23 1992-04-21 Calcitonin enthaltende pharmazeutische zusammensetzungen ATE194775T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB919108634A GB9108634D0 (en)	1991-04-23	1991-04-23	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
ATE194775T1 true ATE194775T1 (de)	2000-08-15

Family

ID=10693744

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92303554T ATE194775T1 (de)	1991-04-23	1992-04-21	Calcitonin enthaltende pharmazeutische zusammensetzungen

Country Status (19)

Country	Link
US (1)	US5593962A (de)
EP (1)	EP0510913B1 (de)
JP (1)	JP3532580B2 (de)
KR (1)	KR100245534B1 (de)
AT (1)	ATE194775T1 (de)
AU (1)	AU653395B2 (de)
CA (1)	CA2066532C (de)
CY (1)	CY2246B1 (de)
DE (1)	DE69231263T2 (de)
DK (1)	DK0510913T3 (de)
ES (1)	ES2150418T3 (de)
GB (1)	GB9108634D0 (de)
GR (1)	GR3034414T3 (de)
IE (1)	IE921278A1 (de)
IL (1)	IL101622A (de)
MX (1)	MX9201825A (de)
NZ (1)	NZ242440A (de)
PT (1)	PT510913E (de)
ZA (1)	ZA922899B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5595760A (en) *	1994-09-02	1997-01-21	Delab	Sustained release of peptides from pharmaceutical compositions
JP2002539172A (ja) *	1999-03-17	2002-11-19	ノバルティスアクチエンゲゼルシャフト	Ｔｇｆ−ベータを含む医薬組成物
AU783952B2 (en)	2000-02-04	2006-01-05	Unigene Laboratories, Inc.	Nasal calcitonin formulations
BRPI0314546B8 (pt)	2002-09-27	2021-05-25	Zentaris Gmbh	composição de gel farmacêutico compreendendo peptídeos farmaceuticamente atvos com liberação sustentada, método para a produção dos mesmos kit.
GB0422644D0 (en) *	2004-10-12	2004-11-10	Novartis Ag	Organic compounds
GB0511269D0 (en)	2005-06-02	2005-07-13	Creative Peptides Sweden Ab	Sustained release preparation of pro-insulin C-peptide
JP2011516541A (ja)	2008-04-07	2011-05-26	ナショナルインスティテュートオブイミュノロジー	糖尿病および他の慢性疾患の治療に有用な組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS61267528A (ja) *	1984-11-26	1986-11-27	Yamanouchi Pharmaceut Co Ltd	吸収促進剤を含有するカルシトニン経鼻剤
MY102411A (en) *	1986-12-23	1992-06-17	Ciba Geigy Ag	Nasal solutions

1991
- 1991-04-23 GB GB919108634A patent/GB9108634D0/en active Pending
1992
- 1992-04-16 IL IL10162292A patent/IL101622A/en active IP Right Grant
- 1992-04-21 AT AT92303554T patent/ATE194775T1/de not_active IP Right Cessation
- 1992-04-21 DK DK92303554T patent/DK0510913T3/da active
- 1992-04-21 EP EP92303554A patent/EP0510913B1/de not_active Expired - Lifetime
- 1992-04-21 CA CA002066532A patent/CA2066532C/en not_active Expired - Fee Related
- 1992-04-21 MX MX9201825A patent/MX9201825A/es not_active IP Right Cessation
- 1992-04-21 PT PT92303554T patent/PT510913E/pt unknown
- 1992-04-21 DE DE69231263T patent/DE69231263T2/de not_active Expired - Fee Related
- 1992-04-21 ES ES92303554T patent/ES2150418T3/es not_active Expired - Lifetime
- 1992-04-22 KR KR1019920006719A patent/KR100245534B1/ko not_active Expired - Fee Related
- 1992-04-22 ZA ZA922899A patent/ZA922899B/xx unknown
- 1992-04-22 NZ NZ242440A patent/NZ242440A/en not_active IP Right Cessation
- 1992-04-22 AU AU15066/92A patent/AU653395B2/en not_active Ceased
- 1992-04-22 JP JP12794192A patent/JP3532580B2/ja not_active Expired - Fee Related
- 1992-04-22 IE IE127892A patent/IE921278A1/en not_active IP Right Cessation
1993
- 1993-08-04 US US08/102,117 patent/US5593962A/en not_active Expired - Lifetime
2000
- 2000-09-15 GR GR20000402102T patent/GR3034414T3/el not_active IP Right Cessation
2001
- 2001-11-19 CY CY0100038A patent/CY2246B1/xx unknown

Also Published As

Publication number	Publication date
CA2066532A1 (en)	1992-10-24
DK0510913T3 (da)	2000-10-16
EP0510913B1 (de)	2000-07-19
DE69231263D1 (de)	2000-08-24
JPH05139993A (ja)	1993-06-08
GR3034414T3 (en)	2000-12-29
ES2150418T3 (es)	2000-12-01
AU653395B2 (en)	1994-09-29
EP0510913A3 (en)	1993-12-15
ZA922899B (en)	1993-10-22
US5593962A (en)	1997-01-14
CA2066532C (en)	2003-08-19
GB9108634D0 (en)	1991-06-12
EP0510913A2 (de)	1992-10-28
IL101622A (en)	1996-06-18
CY2246B1 (en)	2003-07-04
PT510913E (pt)	2000-12-29
DE69231263T2 (de)	2000-12-21
AU1506692A (en)	1992-10-29
KR100245534B1 (ko)	2000-03-02
IL101622A0 (en)	1992-12-30
IE921278A1 (en)	1992-11-04
JP3532580B2 (ja)	2004-05-31
MX9201825A (es)	1992-10-01
NZ242440A (en)	1993-10-26

Similar Documents

Publication	Publication Date	Title
DE60018100D1 (en)	2005-03-17	Polymorphe form von atorvastatin-calcium
DE68909691D1 (de)	1993-11-11	Multischichtkörper zur Abgabe von Duftstoffen.
ATA129892A (de)	1997-07-15	Pharmazeutische zusammensetzung
DE69101931D1 (de)	1994-06-16	Pharmazeutische Zusammensetzung.
LV12284A (lv)	1999-06-20	No kudras izdaliti bioaktivi produkti un tos saturosas farmaceitiskas un kosmetiskas kompozicijas
UA26213C2 (uk)	1999-07-19	Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
DE69019363D1 (de)	1995-06-14	Desinfizierende zusammensetzung und desinfektionsverfahren.
FI972308A0 (fi)	1997-05-30	2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
IL87421A (en)	1992-12-01	Pharmaceutical compositions containing 5-amino (or substituted amino) - 1,2,3-triazoles
SE9802937D0 (sv)	1998-09-01	Novel compounds
DK376188A (da)	1989-01-07	Farmaceutisk dosisenhed
ATE194775T1 (de)	2000-08-15	Calcitonin enthaltende pharmazeutische zusammensetzungen
DE69434210D1 (de)	2005-02-03	Pharmazeutische antacidzusammensetzung
ES2177024T3 (es)	2002-12-01	Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
DE69832722D1 (de)	2006-01-12	L-threonat-eisen, pharmazeutische zusammensetzung und verwendung zur verbesserung und behandlung von anämie bei menschen
MX9202507A (es)	1992-11-01	Composicion farmaceutica para el tratamiento de esofagitis de reflujo.
ATE231728T1 (de)	2003-02-15	Pharmazeutische zusammensetzung enthaltend interferon-gamma stimulatoren
ATE209485T1 (de)	2001-12-15	Kombinationspräparat enthaltend tramadol und einen calcium-kanal antagonisten
DK0495226T3 (da)	1995-11-27	Anvendelse af 3-aryl-5-alkylthio-4H-1,2,4-triazoler til behandling af hyperrefleksi som følge af spinaltrauma
PT661058E (pt)	2004-04-30	Utilizacao de antagonistas da bradiquinina para o tratamento de doencas virais
SE8802323D0 (sv)	1988-06-21	8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
DE69003003D1 (de)	1993-10-07	Pharmazeutische Zusammensetzung.
YU40098A (sh)	1999-09-27	Upotreba olanzapina za dobijanje leka
DE68905343D1 (de)	1993-04-15	Dosisform zur verabreichung von calciumantagonisten.
ATE86481T1 (de)	1993-03-15	Dosisform zur verabreichung von calciumantagonisten.

Legal Events

Date	Code	Title	Description
2011-01-15	REN	Ceased due to non-payment of the annual fee